Medication info

Y2Tren Tablet (Mugwort 95% Ethanol Extract (20→1))

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Artemisiae Argyi Folium 95% Ethanol Soft Extract (20→1)›60mg / 1 tablet
Manufacturer / importer
Sungyi Bio Pharmaceutical Co., Ltd.
Appearance
Green oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202200902 · Notified 2022.03.02

This product's status changed to Approval withdrawn on 2025.07.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of gastric mucosal lesions in acute and chronic gastritis; prevention of NSAID-induced gastritis
Who takes it
Adults
Adult dose
Administer 60 mg orally 3 times daily as a 95% ethanol soft extract of Artemisia princeps.

Ingredients

Manufacturer
Sungyi Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of gastric mucosal lesions in acute and chronic gastritis; prevention of NSAID-induced gastritis

  • Gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
  • chronic gastritis
  • gastritis
View approved original text

This medication helps improve lesions of the gastric mucosa such as erosion, bleeding, redness, and swelling caused by acute and chronic gastritis. It also has the effect of preventing gastritis caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). Therefore, it is effectively used to maintain gastric health and alleviate gastritis symptoms.

How to take

Adult dose

Administer 60 mg orally 3 times daily as a 95% ethanol soft extract of Artemisia princeps.

Precautions

This medication contains lactose and should not be used in patients with genetic issues such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. Patients with thrombosis or consumptive coagulopathy, and patients with serious issues in the liver, kidneys, heart, lungs, or blood should use this medication cautiously. Patients with drug allergy symptoms or a history of allergies should also be careful. This medication contains Yellow No. 4 (Tartrazine), and patients allergic to this component should exercise caution. During use, gastrointestinal symptoms such as nausea, anorexia, diarrhea, vomiting, heartburn, and upper abdominal pain may occur. Neurological symptoms such as dizziness or headache, skin reactions such as rash or itching, and liver function abnormalities can occur rarely. When used in conjunction with non-steroidal anti-inflammatory drugs, symptoms such as abdominal distension, gastrointestinal symptoms, elevated liver values, headaches, insomnia, urinary difficulty, and nasopharyngitis may occur. Abnormal reactions such as anorexia, nausea, dyspepsia, and abdominal pain have been reported in some patients in clinical trials and post-market studies. There has not been sufficient research on patients with a history of peptic ulcers, gastroesophageal reflux disease, or gastric resection, so caution is required. If symptoms do not improve for more than two weeks, discontinue use and consult a healthcare professional. There have not been studies on interactions with other medications, so it is advisable to consult with a healthcare professional if taking other medications. Women who are pregnant or may become pregnant should only use this medication when the benefits of treatment outweigh the risks, as its safety has not been established. Nursing mothers should also use this medication cautiously, as it is not known if the medication is excreted in breast milk. This medication may cause changes in liver function test values, so regular monitoring may be necessary. Keep this medication out of the reach of children, store it in a cool, dry place away from direct sunlight, and keep it tightly sealed to avoid exposure to air or moisture. Transferring the medication to another container may alter its quality, so it is advisable to keep it in the original container.

Side effects

  • nausea
  • appetite loss
  • diarrhea
  • vomiting
  • heartburn
  • epigastric pain
  • dizziness
  • headache
  • rash
  • itching
Show 19 more
  • elevated ALT
  • palpitations
  • abdominal distension
  • lower abdominal pain
  • constipation
  • dyspepsia
  • belching
  • gastrointestinal hypermotility
  • gastroesophageal reflux
  • hunger
  • increased bilirubin levels
  • appetite stimulation
  • insomnia
  • dysuria
  • nasopharyngitis
  • increased LDH levels
  • facial edema
  • upper abdominal pain
  • abdominal pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. By doing so, the effectiveness of the medication can be safely preserved.

Appearance and packaging

Appearance

Green oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.